iTonic Holdings (ITOC) Short-term Investments (2023 - 2025)

iTonic Holdings (ITOC) reported Short-term Investments of $1.4 million for Q4 2025, up 2.56% sequentially from $1.4 million in Q2 2025.

iTonic Holdings (ITOC) Short-term Investments (2023 - 2025) Analysis & Trends

iTonic Holdings (ITOC) has 2 years of Short-term Investments data on file, last reported at $1.4 million in Q4 2025.

For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
Short-term Investments grew to $1.4 million in Q4 2025, from $1.4 million in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $1.4 million in Q4 2025 to a low of $9565.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.40 Bn	176.11 Bn	6.27 Bn
2	Stryker	128.93 Bn	126.05 Bn	3.81 Bn
3	Medtronic	108.35 Bn	99.13 Bn	6.41 Bn
4	Boston Scientific	68.71 Bn	67.25 Bn	3.61 Bn
5	Edwards Lifesciences	48.35 Bn	44.68 Bn	1.29 Bn
6	Dexcom	28.37 Bn	27.25 Bn	750.30 Mn
7	GE HealthCare Technologies	28.04 Bn	25.76 Bn	1.98 Bn
8	Smith & Nephew	26.90 Bn	26.33 Bn	-
9	Koninklijke Philips	24.06 Bn	20.93 Bn	2.07 Bn
10	iTonic Holdings	4.28 Mn	1.35 Mn	-

Download Data